A REVIEW OF TIRZEPATIDE

Semaglutide is revealed to result in medullary thyroid cell carcinoma in rodents. Even though its clinical relevance to people is not known, the FDA advises not to administer this drug in those with a private or family heritage of medullary thyroid carcinoma. Semaglutide also poses a danger of pancreatitis and dehydration.2016). Regardless of the n